Biomanufacturing sales key to Pall’s Q4 growth
Pall has ended fiscal 2010 with strong set of sales after recovering pharmaceutical industry demand for bioproduction tech maintained its momentum in Q4
Archives for September 14, 2010
NexACT enables rectal delivery of biologics, say Apricus Bio
Apricus Biosciences, formerly NexMed, announce preclinical data shows NexACT technology enables rectal delivery of biologics, including human antibodies.
Q Chip scaling up cGMP production using new funding
Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.
Gentronix deal boosts CRL’s genotoxicity service offering
Charles River Laboratories (CRL) is strengthening its genotoxicity screening service by offering Gentronix’s BlueScreen HC.